Mepenzolate

Mepenzolate is a post-ganglionic parasympathetic inhibitor. It decreases gastric acid and pepsin secretion and suppresses spontaneous contractions of the colon. Mepenzolate diminishes gastric acid and pepsin secretion. Mepenzolate also suppresses spontaneous contractions of the colon. Pharmacologically, it is a post-ganglionic parasympathetic inhibitor. It has not been shown to be effective in contributing to the healing of peptic ulcer, decreasing the rate of recurrence, or preventing complications. It is grouped under the following drug class(es): Anticholinergics. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Mepenzolic acid and Mepenzolate cation. Its PubChem CID is 4057.

CAS No 25990-43-6
Molecular Formula C21H26NO3+
Molecular Weight 340.40 g/mol
Synonyms (1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenylacetate

Frequently Asked Questions